Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
Clinical trial NCT04786093 · TERMINATED
Trial details
- NCT number
- NCT04786093
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2022-06-09
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.